• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>NPS Pharmaceuticals

NPS Pharmaceuticals

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Five Things You Should Know About U.S. Small-Caps

    NPS Pharmaceuticals NPSP raised $50 million Monday through the sale of its Preotact royalty stream to Drug Royalty Corporation. We're maintaining our fair value estimate as we believe the exchange was fair but not favorable to shareholders. The proceeds will satisfy part of a $190 million ...

  2. Foreign Takeovers See U.S. Losing Tax Revenue

    Foreign Takeovers See U.S. Losing Tax Revenue

  3. Biotech Bidding War Yields Rich Price

    Biotech Bidding War Yields Rich Price

  4. Research and Markets: Secondary Hyperparathyroidism Pipeline Review 2015 - 6 Companies & 14 Drug Profiles

    Research and Markets: Secondary Hyperparathyroidism Pipeline Review 2015 - 6 Companies & 14 Drug Profiles

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.